Pepdox
Studies
Peptides
Calculator
Semaglutide, the first approved GLP-1 receptor agonist for the management of metabolic dysfunction-associated steatohepatitis. | Pepdox
Home
/
Search
/
PMID 41047002
Semaglutide, the first approved GLP-1 receptor agonist for the management of metabolic dysfunction-associated steatohepatitis.
Metabolism: clinical and experimental
2026
PMID: 41047002
View on PubMed
DOI: 10.1016/j.metabol.2025.156397
Semaglutide
Authors
Boutari, Chrysoula; Hill, Michael A; Mantzoros, Christos S